Analysis of Economic Losses to Patent Medicine that Stagnant in Surabaya, Indonesia

Dwi Ratnasari, Thinni Nurul Rochmah

2017

Abstract

Ineffective and inefficient drug management can result in the stagnation of hospital supplies and can bring aboutnegative consequences, one of which is economic losses. Patent medicine is one type of drug used in drug services for general patients at the Islamic Hospital of Surabaya. The stagnation of patent medicine at Pharmacy Unit Islamic Hospital of Surabaya was at26.42% in October 2016 to March 2017. The objective of this research study is to analyse the amount of economic losses due to the stagnation of patent medicine at the Islamic Hospital of Surabaya. This was a descriptive observational research study and used a cross-sectional design. The study was conducted on 299 patent medicines at Islamic Hospital of Surabaya. The results showed there were some effects of stagnation including increased holding costs, embedded capital, loss of ordering costs, increased risk of damage and expiration, as well as increasing extermination costs. The total economic losses due to patent medicines that stagnated in October 2016 to March 2017 amounting to IDR 41.276.489(1 USD = IDR 13.513). The conclusion showed that the drug management system is still ineffective and inefficient, so that it can causes losses. The recommendation that can be given is to improve the hospital’s management information and drug management system.

Paper Citation

in Harvard Style

Ratnasari D. and Rochmah T. (2017). Analysis of Economic Losses to Patent Medicine that Stagnant in Surabaya, Indonesia.In Proceedings of the 4th Annual Meeting of the Indonesian Health Economics Association - Volume 1: INAHEA, ISBN 978-989-758-335-3, pages 218-221. DOI: 10.5220/0007027502180221

in Bibtex Style

@conference{inahea17,
author={Dwi Ratnasari and Thinni Nurul Rochmah},
title={Analysis of Economic Losses to Patent Medicine that Stagnant in Surabaya, Indonesia},
booktitle={Proceedings of the 4th Annual Meeting of the Indonesian Health Economics Association - Volume 1: INAHEA,},
year={2017},
pages={218-221},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0007027502180221},
isbn={978-989-758-335-3},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th Annual Meeting of the Indonesian Health Economics Association - Volume 1: INAHEA,
TI - Analysis of Economic Losses to Patent Medicine that Stagnant in Surabaya, Indonesia
SN - 978-989-758-335-3
AU - Ratnasari D.
AU - Rochmah T.
PY - 2017
SP - 218
EP - 221
DO - 10.5220/0007027502180221